Summary
With the recent discovery of JAK2 mutations in myeloproliferative disorders is a revolutionary stride forward for in understanding the pathogenesis of these disorders. This new advancement translates to a more rapid and reliable diagnosis, and allows for groundbreaking research into the development of new therapeutics. Written in an easy-to-follow source myeloproliferative disorders gives the practicing clinician s single source answer to classification, diagnosis, management, and all recent advances in this disorder.
|